ID   AHSA1_HUMAN             Reviewed;         338 AA.
AC   O95433; B2R9L2; B4DUR9; Q96IL6; Q9P060;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   28-JAN-2026, entry version 213.
DE   RecName: Full=Activator of 90 kDa heat shock protein ATPase homolog 1;
DE            Short=AHA1;
DE   AltName: Full=p38;
GN   Name=AHSA1; Synonyms=C14orf3; ORFNames=HSPC322;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Michaud J., Chrast R., Rossier C., Papassavas M.P., Antonarakis S.E.,
RA   Scott H.S.;
RT   "Isolation of a novel gene underexpressed in Down syndrome.";
RL   Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Adrenal gland;
RX   PubMed=10931946; DOI=10.1073/pnas.160270997;
RA   Hu R.-M., Han Z.-G., Song H.-D., Peng Y.-D., Huang Q.-H., Ren S.-X.,
RA   Gu Y.-J., Huang C.-H., Li Y.-B., Jiang C.-L., Fu G., Zhang Q.-H., Gu B.-W.,
RA   Dai M., Mao Y.-F., Gao G.-F., Rong R., Ye M., Zhou J., Xu S.-H., Gu J.,
RA   Shi J.-X., Jin W.-R., Zhang C.-K., Wu T.-M., Huang G.-Y., Chen Z.,
RA   Chen M.-D., Chen J.-L.;
RT   "Gene expression profiling in the human hypothalamus-pituitary-adrenal axis
RT   and full-length cDNA cloning.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:9543-9548(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
RA   Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
RA   Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
RA   Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
RA   Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
RA   Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
RA   Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
RA   Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
RA   Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
RA   Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
RA   Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
RA   Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
RA   Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
RA   Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung, and Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 67-338 (ISOFORM 1).
RC   TISSUE=Umbilical cord blood;
RX   PubMed=11042152; DOI=10.1101/gr.140200;
RA   Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G.,
RA   Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W.,
RA   Tao J., Huang Q.-H., Zhou J., Hu G.-X., Gu J., Chen S.-J., Chen Z.;
RT   "Cloning and functional analysis of cDNAs with open reading frames for 300
RT   previously undefined genes expressed in CD34+ hematopoietic stem/progenitor
RT   cells.";
RL   Genome Res. 10:1546-1560(2000).
RN   [8]
RP   INTERACTION WITH VSV G, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11554768; DOI=10.1006/bbrc.2001.5621;
RA   Sevier C.S., Machamer C.E.;
RT   "p38: a novel protein that associates with the vesicular stomatitis virus
RT   glycoprotein.";
RL   Biochem. Biophys. Res. Commun. 287:574-582(2001).
RN   [9]
RP   INTERACTION WITH HSPCA, IDENTIFICATION BY MASS SPECTROMETRY, AND INDUCTION.
RX   PubMed=12504007; DOI=10.1016/s1097-2765(02)00785-2;
RA   Panaretou B., Siligardi G., Meyer P., Maloney A., Sullivan J.K., Singh S.,
RA   Millson S.H., Clarke P.A., Naaby-Hansen S., Stein R., Cramer R.,
RA   Mollapour M., Workman P., Piper P.W., Pearl L.H., Prodromou C.;
RT   "Activation of the ATPase activity of hsp90 by the stress-regulated
RT   cochaperone aha1.";
RL   Mol. Cell 10:1307-1318(2002).
RN   [10]
RP   INTERACTION WITH HSPCA.
RX   PubMed=12604615; DOI=10.1074/jbc.m212761200;
RA   Lotz G.P., Lin H., Harst A., Obermann W.M.J.;
RT   "Aha1 binds to the middle domain of Hsp90, contributes to client protein
RT   activation, and stimulates the ATPase activity of the molecular
RT   chaperone.";
RL   J. Biol. Chem. 278:17228-17235(2003).
RN   [11]
RP   INTERACTION WITH GCH1.
RX   PubMed=16696853; DOI=10.1111/j.1471-4159.2006.03836.x;
RA   Swick L., Kapatos G.;
RT   "A yeast 2-hybrid analysis of human GTP cyclohydrolase I protein
RT   interactions.";
RL   J. Neurochem. 97:1447-1455(2006).
RN   [12]
RP   INTERACTION WITH SRPK1.
RX   PubMed=19240134; DOI=10.1101/gad.1752109;
RA   Zhong X.Y., Ding J.H., Adams J.A., Ghosh G., Fu X.D.;
RT   "Regulation of SR protein phosphorylation and alternative splicing by
RT   modulating kinetic interactions of SRPK1 with molecular chaperones.";
RL   Genes Dev. 23:482-495(2009).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-3 AND LYS-212, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-193, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-193, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-258, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-182, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [20]
RP   FUNCTION, AND INTERACTION WITH FLCN AND HSP90AA1.
RX   PubMed=27353360; DOI=10.1038/ncomms12037;
RA   Woodford M.R., Dunn D.M., Blanden A.R., Capriotti D., Loiselle D.,
RA   Prodromou C., Panaretou B., Hughes P.F., Smith A., Ackerman W.,
RA   Haystead T.A., Loh S.N., Bourboulia D., Schmidt L.S., Marston Linehan W.,
RA   Bratslavsky G., Mollapour M.;
RT   "The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance
RT   drug binding.";
RL   Nat. Commun. 7:12037-12037(2016).
RN   [21]
RP   FUNCTION, INTERACTION WITH HSP90AA1, PHOSPHORYLATION AT TYR-223, AND
RP   MUTAGENESIS OF TYR-223.
RX   PubMed=29127155; DOI=10.15252/embj.201796700;
RA   Woodford M.R., Sager R.A., Marris E., Dunn D.M., Blanden A.R., Murphy R.L.,
RA   Rensing N., Shapiro O., Panaretou B., Prodromou C., Loh S.N., Gutmann D.H.,
RA   Bourboulia D., Bratslavsky G., Wong M., Mollapour M.;
RT   "Tumor suppressor Tsc1 is a new Hsp90 co-chaperone that facilitates folding
RT   of kinase and non-kinase clients.";
RL   EMBO J. 36:3650-3665(2017).
RN   [22]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-203, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [23]
RP   STRUCTURE BY NMR OF 204-335.
RG   RIKEN structural genomics initiative (RSGI);
RT   "The solution structure of the C-terminal domain of human activator of 90
RT   kDa heat shock protein ATPase homolog 1.";
RL   Submitted (NOV-2005) to the PDB data bank.
CC   -!- FUNCTION: Acts as a co-chaperone of HSP90AA1 (PubMed:29127155).
CC       Activates the ATPase activity of HSP90AA1 leading to increase in its
CC       chaperone activity (PubMed:29127155). Competes with the inhibitory co-
CC       chaperone FNIP1 for binding to HSP90AA1, thereby providing a reciprocal
CC       regulatory mechanism for chaperoning of client proteins
CC       (PubMed:27353360). Competes with the inhibitory co-chaperone TSC1 for
CC       binding to HSP90AA1, thereby providing a reciprocal regulatory
CC       mechanism for chaperoning of client proteins (PubMed:29127155).
CC       {ECO:0000269|PubMed:27353360, ECO:0000269|PubMed:29127155}.
CC   -!- SUBUNIT: Interacts with HSPCA/HSP90 (PubMed:12504007, PubMed:12604615).
CC       Interacts (phosphorylated on Tyr-223) with HSP90AA1; the interaction
CC       activates HSP90AA1 ATPase activity (PubMed:27353360, PubMed:29127155).
CC       Interacts with HSP90AB1 (By similarity). Interacts with GCH1
CC       (PubMed:16696853). Interacts with SRPK1 (PubMed:19240134). Interacts
CC       with FLCN (PubMed:27353360). {ECO:0000250|UniProtKB:Q8BK64,
CC       ECO:0000269|PubMed:12504007, ECO:0000269|PubMed:12604615,
CC       ECO:0000269|PubMed:16696853, ECO:0000269|PubMed:19240134,
CC       ECO:0000269|PubMed:27353360, ECO:0000269|PubMed:29127155}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with vesicular stomatitis
CC       virus glycoprotein (VSV G) (via cytoplasmic tail).
CC       {ECO:0000269|PubMed:11554768}.
CC   -!- INTERACTION:
CC       O95433; P30793: GCH1; NbExp=3; IntAct=EBI-448610, EBI-958183;
CC       O95433; P07900: HSP90AA1; NbExp=6; IntAct=EBI-448610, EBI-296047;
CC       O95433; P08238: HSP90AB1; NbExp=5; IntAct=EBI-448610, EBI-352572;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:11554768}.
CC       Endoplasmic reticulum {ECO:0000269|PubMed:11554768}. Note=May
CC       transiently interact with the endoplasmic reticulum.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O95433-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95433-2; Sequence=VSP_055797;
CC   -!- TISSUE SPECIFICITY: Expressed in numerous tissues, including brain,
CC       heart, skeletal muscle and kidney and, at lower levels, liver and
CC       placenta. {ECO:0000269|PubMed:11554768}.
CC   -!- INDUCTION: By heat shock and treatment with the HSP90 inhibitor 17-
CC       demethoxygeldanamycin (17AAG). {ECO:0000269|PubMed:12504007}.
CC   -!- PTM: Phosphorylation at Tyr-223 enhances binding to chaperone HSP90AA1.
CC       {ECO:0000269|PubMed:29127155}.
CC   -!- SIMILARITY: Belongs to the AHA1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ243310; CAB45684.1; -; mRNA.
DR   EMBL; AF164791; AAF80755.1; -; mRNA.
DR   EMBL; AK300766; BAG62431.1; -; mRNA.
DR   EMBL; AK313824; BAG36559.1; -; mRNA.
DR   EMBL; AF111168; AAD09623.1; -; Genomic_DNA.
DR   EMBL; CH471061; EAW81291.1; -; Genomic_DNA.
DR   EMBL; BC000321; AAH00321.1; -; mRNA.
DR   EMBL; BC007398; AAH07398.2; -; mRNA.
DR   EMBL; AF161440; AAF29000.1; -; mRNA.
DR   CCDS; CCDS9863.1; -. [O95433-1]
DR   PIR; JC7769; JC7769.
DR   RefSeq; NP_001308370.1; NM_001321441.1.
DR   RefSeq; NP_036243.1; NM_012111.3. [O95433-1]
DR   PDB; 1X53; NMR; -; A=204-335.
DR   PDB; 7DMD; NMR; -; A=28-162.
DR   PDB; 7DME; NMR; -; A=28-335.
DR   PDB; 8Z3H; X-ray; 1.50 A; A=204-335.
DR   PDB; 8Z3J; X-ray; 1.52 A; A=204-335.
DR   PDBsum; 1X53; -.
DR   PDBsum; 7DMD; -.
DR   PDBsum; 7DME; -.
DR   PDBsum; 8Z3H; -.
DR   PDBsum; 8Z3J; -.
DR   AlphaFoldDB; O95433; -.
DR   BMRB; O95433; -.
DR   SMR; O95433; -.
DR   BioGRID; 115846; 300.
DR   FunCoup; O95433; 2416.
DR   IntAct; O95433; 97.
DR   MINT; O95433; -.
DR   STRING; 9606.ENSP00000216479; -.
DR   ChEMBL; CHEMBL3309113; -.
DR   TCDB; 8.A.163.1.1; the hsp90/cdc37 (hsp90/cdc37) family.
DR   GlyGen; O95433; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O95433; -.
DR   MetOSite; O95433; -.
DR   PhosphoSitePlus; O95433; -.
DR   SwissPalm; O95433; -.
DR   BioMuta; AHSA1; -.
DR   REPRODUCTION-2DPAGE; IPI00030706; -.
DR   jPOST; O95433; -.
DR   MassIVE; O95433; -.
DR   PaxDb; 9606-ENSP00000216479; -.
DR   PeptideAtlas; O95433; -.
DR   ProteomicsDB; 50878; -. [O95433-1]
DR   ProteomicsDB; 5208; -.
DR   Pumba; O95433; -.
DR   Antibodypedia; 54; 836 antibodies from 37 providers.
DR   DNASU; 10598; -.
DR   Ensembl; ENST00000216479.8; ENSP00000216479.3; ENSG00000100591.9. [O95433-1]
DR   Ensembl; ENST00000535854.6; ENSP00000440108.2; ENSG00000100591.9. [O95433-2]
DR   GeneID; 10598; -.
DR   KEGG; hsa:10598; -.
DR   MANE-Select; ENST00000216479.8; ENSP00000216479.3; NM_012111.3; NP_036243.1.
DR   UCSC; uc001xtw.4; human. [O95433-1]
DR   AGR; HGNC:1189; -.
DR   ClinPGx; PA25515; -.
DR   CTD; 10598; -.
DR   DisGeNET; 10598; -.
DR   GeneCards; AHSA1; -.
DR   HGNC; HGNC:1189; AHSA1.
DR   HPA; ENSG00000100591; Low tissue specificity.
DR   MalaCards; AHSA1; -.
DR   MIM; 608466; gene.
DR   OpenTargets; ENSG00000100591; -.
DR   VEuPathDB; HostDB:ENSG00000100591; -.
DR   eggNOG; KOG2936; Eukaryota.
DR   GeneTree; ENSGT00940000155144; -.
DR   HOGENOM; CLU_049046_0_0_1; -.
DR   InParanoid; O95433; -.
DR   OMA; HIAMKWR; -.
DR   OrthoDB; 567237at2759; -.
DR   PAN-GO; O95433; 4 GO annotations based on evolutionary models.
DR   PhylomeDB; O95433; -.
DR   PathwayCommons; O95433; -.
DR   SignaLink; O95433; -.
DR   SIGNOR; O95433; -.
DR   Agora; ENSG00000100591; -.
DR   BioGRID-ORCS; 10598; 32 hits in 1161 CRISPR screens.
DR   CD-CODE; DEE660B4; Stress granule.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; AHSA1; human.
DR   EvolutionaryTrace; O95433; -.
DR   GeneWiki; AHSA1; -.
DR   GenomeRNAi; 10598; -.
DR   Pharos; O95433; Tbio.
DR   PRO; PR:O95433; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; O95433; protein.
DR   Bgee; ENSG00000100591; Expressed in oocyte and 210 other cell types or tissues.
DR   ExpressionAtlas; O95433; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0001671; F:ATPase activator activity; IDA:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0051879; F:Hsp90 protein binding; IPI:UniProtKB.
DR   GO; GO:0044183; F:protein folding chaperone; IDA:DisProt.
DR   GO; GO:0051087; F:protein-folding chaperone binding; IDA:UniProtKB.
DR   GO; GO:0051082; F:unfolded protein binding; EXP:DisProt.
DR   GO; GO:0036506; P:maintenance of unfolded protein; IDA:DisProt.
DR   GO; GO:0032781; P:positive regulation of ATP-dependent activity; IDA:UniProtKB.
DR   GO; GO:0006457; P:protein folding; IBA:GO_Central.
DR   CDD; cd08892; SRPBCC_Aha1; 1.
DR   DisProt; DP04219; -.
DR   FunFam; 3.15.10.20:FF:000001; Activator of 90 kDa heat shock protein ATPase 1; 1.
DR   FunFam; 3.30.530.20:FF:000018; Activator of 90 kDa heat shock protein ATPase 1; 1.
DR   Gene3D; 3.30.530.20; -; 1.
DR   Gene3D; 3.15.10.20; Activator of Hsp90 ATPase Aha1, N-terminal domain; 1.
DR   InterPro; IPR036338; Aha1.
DR   InterPro; IPR015310; AHSA1-like_N.
DR   InterPro; IPR013538; ASHA1/2-like_C.
DR   InterPro; IPR023393; START-like_dom_sf.
DR   PANTHER; PTHR13009:SF7; ACTIVATOR OF 90 KDA HEAT SHOCK PROTEIN ATPASE HOMOLOG 1; 1.
DR   PANTHER; PTHR13009; HEAT SHOCK PROTEIN 90 HSP90 CO-CHAPERONE AHA-1; 1.
DR   Pfam; PF09229; Aha1_N; 1.
DR   Pfam; PF08327; AHSA1; 1.
DR   SMART; SM01000; Aha1_N; 1.
DR   SUPFAM; SSF103111; Activator of Hsp90 ATPase, Aha1; 1.
DR   SUPFAM; SSF55961; Bet v1-like; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Chaperone; Cytoplasm;
KW   Endoplasmic reticulum; Host-virus interaction; Isopeptide bond;
KW   Phosphoprotein; Proteomics identification; Reference proteome;
KW   Stress response; Ubl conjugation.
FT   CHAIN           1..338
FT                   /note="Activator of 90 kDa heat shock protein ATPase
FT                   homolog 1"
FT                   /id="PRO_0000215820"
FT   MOD_RES         3
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         193
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         212
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         223
FT                   /note="Phosphotyrosine; by ABL"
FT                   /evidence="ECO:0000305|PubMed:29127155"
FT   MOD_RES         258
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   CROSSLNK        182
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0007744|PubMed:25114211"
FT   CROSSLNK        203
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         283..338
FT                   /note="HFATITLTFIDKNGETELCMEGRGIPAPEEERTRQGWQRYYFEGIKQTFGYG
FT                   ARLF -> SHCHSG (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055797"
FT   MUTAGEN         223
FT                   /note="Y->E: Phosphomimetic mutant. Increases the binding
FT                   to HSP90AA1 resulting in TSC1 dissociation from HSP90AA1."
FT                   /evidence="ECO:0000269|PubMed:29127155"
FT   CONFLICT        67..68
FT                   /note="EA -> CL (in Ref. 7; AAF29000)"
FT                   /evidence="ECO:0000305"
FT   HELIX           33..44
FT                   /evidence="ECO:0007829|PDB:7DMD"
FT   HELIX           52..54
FT                   /evidence="ECO:0007829|PDB:7DME"
FT   STRAND          57..61
FT                   /evidence="ECO:0007829|PDB:7DMD"
FT   STRAND          65..71
FT                   /evidence="ECO:0007829|PDB:7DMD"
FT   STRAND          73..75
FT                   /evidence="ECO:0007829|PDB:7DME"
FT   STRAND          78..93
FT                   /evidence="ECO:0007829|PDB:7DMD"
FT   TURN            94..96
FT                   /evidence="ECO:0007829|PDB:7DMD"
FT   STRAND          97..99
FT                   /evidence="ECO:0007829|PDB:7DMD"
FT   STRAND          102..105
FT                   /evidence="ECO:0007829|PDB:7DMD"
FT   STRAND          120..122
FT                   /evidence="ECO:0007829|PDB:7DMD"
FT   STRAND          124..127
FT                   /evidence="ECO:0007829|PDB:7DMD"
FT   TURN            128..130
FT                   /evidence="ECO:0007829|PDB:7DMD"
FT   HELIX           131..159
FT                   /evidence="ECO:0007829|PDB:7DMD"
FT   STRAND          206..217
FT                   /evidence="ECO:0007829|PDB:1X53"
FT   HELIX           219..225
FT                   /evidence="ECO:0007829|PDB:1X53"
FT   HELIX           229..235
FT                   /evidence="ECO:0007829|PDB:1X53"
FT   STRAND          249..252
FT                   /evidence="ECO:0007829|PDB:7DME"
FT   TURN            253..256
FT                   /evidence="ECO:0007829|PDB:1X53"
FT   STRAND          261..265
FT                   /evidence="ECO:0007829|PDB:1X53"
FT   TURN            266..268
FT                   /evidence="ECO:0007829|PDB:1X53"
FT   STRAND          269..276
FT                   /evidence="ECO:0007829|PDB:1X53"
FT   STRAND          285..290
FT                   /evidence="ECO:0007829|PDB:1X53"
FT   STRAND          298..308
FT                   /evidence="ECO:0007829|PDB:1X53"
FT   HELIX           309..317
FT                   /evidence="ECO:0007829|PDB:1X53"
FT   TURN            318..323
FT                   /evidence="ECO:0007829|PDB:1X53"
FT   HELIX           324..330
FT                   /evidence="ECO:0007829|PDB:1X53"
SQ   SEQUENCE   338 AA;  38274 MW;  E6B686DDD8D7D729 CRC64;
     MAKWGEGDPR WIVEERADAT NVNNWHWTER DASNWSTDKL KTLFLAVQVQ NEEGKCEVTE
     VSKLDGEASI NNRKGKLIFF YEWSVKLNWT GTSKSGVQYK GHVEIPNLSD ENSVDEVEIS
     VSLAKDEPDT NLVALMKEEG VKLLREAMGI YISTLKTEFT QGMILPTMNG ESVDPVGQPA
     LKTEERKAKP APSKTQARPV GVKIPTCKIT LKETFLTSPE ELYRVFTTQE LVQAFTHAPA
     TLEADRGGKF HMVDGNVSGE FTDLVPEKHI VMKWRFKSWP EGHFATITLT FIDKNGETEL
     CMEGRGIPAP EEERTRQGWQ RYYFEGIKQT FGYGARLF
//
